Cyltezo

adalimumab · Boehringer Ingelheim International GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cyltezo, covering 2019-03-06 to 2019-03-06. Get the full timeline:

Most recent: EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH